Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)

Erol, Cihan; Sakin, Abdullah; Basoglu, Tugba; Ozden, Ercan; ÇABUK, DEVRİM; Dogan, Mutlu; Oksuzoglu, Berna; YILDIRIM, HASAN; Oner, Irem; Eryilmaz, Melek; Dulgar, Ozgecan; Aydin, Dincer; Dogan, Neslihan; Ozen, Mirac; HACIBEKİROĞLU, İLHAN; ÖZDEMİR, NURİYE; Gurler, Fatih; Paksoy, Nail; Karabulut, Senem; AKSOY, ASUDE; Hizal, Mutlu; KAHRAMAN, SEDA; Sen, Erdem; PAYDAŞ, SEMRA; Cilbir, Ebru; FIRAT ATAY, FEYZA; Akdeniz, Nadiye; Ozcelik, Melike; Oyman, Abdilkerim; Baytemur, Naziyet; Acar, Ramazan; Almuradova, Elvina; KARABULUT, BÜLENT; Sakalar, Teoman; Arak, Haci; Degerli, Ezgi; Turker, Sema; Alan, Ozkan; Er, Ozlem; Tasci, Elif; DEMİR, NAZAN; Cavdar, Eyyup; Turhal, Serdar; ŞENER DEDE, DİDEM; AKINCI, MUHAMMED; YALÇIN, BÜLENT; Yumuk, Fulden; YALÇIN, ŞUAYİB; ŞENDUR, MEHMET

doi:10.55730/1300-0144.5404

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)

Atıf İçin Kopyala

Erol C., Sakin A., Basoglu T., Ozden E., ÇABUK D., Dogan M., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.4, ss.1022-1032, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 52 Sayı: 4
Basım Tarihi: 2022
Doi Numarası: 10.55730/1300-0144.5404
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.1022-1032
Anahtar Kelimeler: FLOT chemotherapy, perioperative treatment, gastric cancer, GEJ tumor, prognostic factor, NEUTROPHIL-LYMPHOCYTE RATIO, CHEMOTHERAPY, ADENOCARCINOMA, SURVIVAL, PLATELET, NOMOGRAM, SURGERY, CANCER
İnönü Üniversitesi Adresli: Hayır

Özet

Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in real-life gastric and GEJ tumors.